Biotechnology
Investing News
Market News
Technology
Protalix BioTherapeutics Announces First Quarter Financial Results
Protalix BioTherapeutics (NYSE: PLX) (TASE: PLX) has reported financial results for the first quarter and a business update on corporate and clinical developments. More will be discussed by the...